The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Pediatric Rhabdomyosarcoma (RMS): Multimodal Care

Most common soft tissue sarcoma in childhood requiring tailored therapy

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Onkoloji department. Book Appointment →

What is Pediatric Rhabdomyosarcoma (RMS): Multimodal Care?

RMS represents about 4 percent of pediatric malignancies with peak incidence under age 10.

Major histologic subtypes are embryonal (60 percent), alveolar (20 percent) and rare pleomorphic and spindle cell variants.

Alveolar RMS frequently harbors PAX3-FOXO1 or PAX7-FOXO1 gene fusions that confer worse prognosis.

Common primary sites include head and neck (35 to 40 percent), genitourinary (25 percent), extremities (20 percent) and trunk.

Risk stratification incorporates histology, fusion status, primary site, tumor size and stage to guide treatment intensity.

Symptoms

Painless mass enlarging over weeks to months, often noted by parents or during routine examination.
Symptoms depend on location with proptosis, ptosis or diplopia in orbital RMS.
Genitourinary involvement causing urinary symptoms, vaginal bleeding or testicular swelling.
Head and neck masses, sinusitis-like symptoms or cranial nerve palsies in parameningeal disease.
Constitutional symptoms with weight loss, fever or fatigue with metastatic disease.

Risk Factors

Cancer predisposition syndromes including Li-Fraumeni, Beckwith-Wiedemann, Costello, Noonan and DICER1.
Neurofibromatosis type 1 increases risk for soft tissue sarcomas including RMS.
Family history of childhood cancer or sarcoma.
Specific molecular alterations particularly PAX/FOXO1 fusions.
Most cases occur sporadically without identifiable predisposing factors.

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Persistent or enlarging mass in any anatomic location in a child requires evaluation.
  • Visual changes, eye protrusion, hearing loss or new cranial nerve symptoms warrant prompt assessment.
  • Genitourinary symptoms including urinary obstruction, bleeding or testicular mass need urgent evaluation.
  • New seizures, headaches or neurologic symptoms may indicate parameningeal extension.
  • Long-term survivorship monitoring detects late effects including secondary malignancies, organ dysfunction and growth disturbances.

Treatment Methods

01
Multimodal therapy combining surgery, chemotherapy and radiation is required for nearly all patients.
02
Standard chemotherapy includes vincristine, actinomycin D and cyclophosphamide (VAC) with risk-adapted intensification.
03
Maximal safe surgical resection when feasible without compromising function and form is pursued.
04
Radiation therapy is delivered to areas of residual disease, with proton therapy increasingly used in pediatric patients.
05
Risk-adapted treatment based on subgroup with novel agents including IGF-1R inhibitors and immunotherapy in clinical trials; multidisciplinary pediatric oncology, surgical, radiation oncology and supportive care including fertility preservation, neurocognitive monitoring and family-centered care optimize outcomes.

Which Department to Visit?

You can visit our Onkoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Onkoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.